SBK Pharma SRL
SBK Pharma reported total assets of 256,504 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
The score of SBK Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +111 % Total assets +18 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
SBK Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 21 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
SBK Pharma's financial analysis
- Solvency17.0%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of SBK Pharma
SBK Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0782.437.533
- VAT number
- BE0782437533
- Peppol
- Registered · 0208:0782437533 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Feb 2022
- Registered office
- 4970 Stavelot
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
SBK Pharma (SRL) has been based in Stavelot since 2022, active in: activities of holding companies. For 2025, it reports a net profit of 8,967 € and equity of 43,628 €; its revenue is not published. Its solvency stands at 17.0%, below the median of its sector (46.9%).
Companies similar to SBK Pharma
Companies in the same business, of comparable size and area, outside its group.
- ECO-M Activities of holding companies Namur · balance sheet 256,735 €
- Arabesk-IR Activities of holding companies Nazareth-De Pinte · balance sheet 256,853 €
- Industrial Support Activities of holding companies Estaimpuis · balance sheet 304,317 €
- Kevago Activities of holding companies Malle · balance sheet 256,028 €
- BlueAlp Oostende Holding Activities of holding companies Ostend · balance sheet 181,128 €
- 4-Foresee Activities of holding companies Zulte · balance sheet 257,215 €
- THVS Activities of holding companies Zwevegem · balance sheet 255,620 €
- Rotra Activities of holding companies Lommel · balance sheet 257,396 €
Frequently asked questions about SBK Pharma
What is the revenue of SBK Pharma?
SBK Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of SBK Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0782437533 for SBK Pharma, if the company is VAT-registered. Its company number (CBE) is 0782.437.533.
Where is the registered office of SBK Pharma?
According to the CBE register, the registered office of SBK Pharma is in 4970 Stavelot.
What is the equity of SBK Pharma?
At the close of the 2025 financial year, the equity of SBK Pharma amounts to 43,628 €, a solvency of 17.0% of total assets.
Who manages SBK Pharma?
The register lists 1 active mandates at SBK Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of SBK Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →